UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 133 filers reported holding UNIQURE NV in Q1 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $500,948 | -90.1% | 74,657 | -83.0% | 0.00% | -81.8% |
| Q2 2023 | $5,044,692 | +81.1% | 440,200 | +218.3% | 0.01% | +120.0% |
| Q1 2023 | $2,785,725 | -52.3% | 138,318 | -46.3% | 0.01% | -44.4% |
| Q4 2022 | $5,843,397 | +182.6% | 257,759 | +133.9% | 0.01% | +200.0% |
| Q3 2022 | $2,068,000 | +2.2% | 110,216 | +1.6% | 0.00% | +50.0% |
| Q2 2022 | $2,023,000 | +34.2% | 108,531 | +30.1% | 0.00% | +100.0% |
| Q1 2022 | $1,508,000 | -61.5% | 83,445 | -55.8% | 0.00% | -66.7% |
| Q4 2021 | $3,919,000 | -44.7% | 188,996 | -14.6% | 0.00% | -40.0% |
| Q3 2021 | $7,086,000 | +5.3% | 221,368 | +1.3% | 0.01% | -16.7% |
| Q2 2021 | $6,730,000 | +1078.6% | 218,494 | +1307.8% | 0.01% | – |
| Q3 2020 | $571,000 | -78.4% | 15,520 | -64.9% | 0.00% | -100.0% |
| Q1 2019 | $2,641,000 | -56.5% | 44,279 | -79.0% | 0.00% | -62.5% |
| Q4 2018 | $6,069,000 | -62.6% | 210,579 | -52.8% | 0.01% | -57.9% |
| Q3 2018 | $16,227,000 | +5.7% | 445,920 | +9.8% | 0.02% | -13.6% |
| Q2 2018 | $15,357,000 | +3327.9% | 406,269 | +1677.4% | 0.02% | +2100.0% |
| Q4 2017 | $448,000 | – | 22,858 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |